Is Less More: Does Leukopenia Predict Remission in Patients with Inflammatory Bowel Disease Receiving Thiopurine Treatment?

被引：2
|
作者：
Gisbert, Javier P. [1 ,2 ]
机构：
[1] Hosp Univ La Princesa, Gastroenterol Unit, Inst Invest Sanitaria Princesa, Madrid 28669, Spain
[2] Hosp Univ La Princesa, Ctr Invest Biomed Red Enfermedades Hepaticas & Di, Madrid 28669, Spain
来源：
DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 01期
关键词：
AZATHIOPRINE THERAPY; 6-MERCAPTOPURINE; NEUTROPENIA;
D O I：
10.1007/s10620-014-3481-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 50 条
  • [21] thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease
    Benitez, J. M.
    Garcia-Sanchez, V.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 494 - 495
  • [22] No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease
    Lindqvist, M.
    Hindorf, U.
    Almer, S.
    Soderkvist, P.
    Strom, M.
    Hjortswang, H.
    Peterson, C.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2006, 25 (9-11): : 1033 - 1037
  • [23] THIOPURINE WITHDRAWAL DURING REMISSION IN INFLAMMATORY BOWEL DISEASE: RELAPSE AND RECAPTURE RATES IN 72 PATIENTS
    Heather
    Wade, Katharine
    Radhakrishnan, Parvathy
    McLaughlin, Simon
    GUT, 2019, 68 : A60 - A60
  • [24] NUDT15 Variant in Thiopurine-Induced Leukopenia among Malaysian Patients with Inflammatory Bowel Disease
    Wong, Shin Yee
    Lee, Way Seah
    Leow, Hwong Ruey
    Ng, Ruey Terng
    Hilmi, Ida Normiha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 157 - 157
  • [25] Novel Strategies in the Thiopurine Treatment of Inflammatory Bowel Disease
    Almer, S.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2010, 29 (4-6): : 267 - 277
  • [26] The Use of Thiopurine Derivatives in the Treatment of Inflammatory Bowel Disease
    Puri, Basant K.
    REVIEWS ON RECENT CLINICAL TRIALS, 2019, 14 (04) : 230 - 231
  • [27] Editorial: thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease
    Fraser, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 227 - 228
  • [28] Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
    Zakerska-Banaszak, Oliwia
    Lykowska-Szuber, Liliana
    Walczak, Michal
    Zuraszek, Joanna
    Zielinska, Aleksandra
    Skrzypczak-Zielinska, Marzena
    TOXICS, 2022, 10 (04)
  • [29] Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis
    Chao, Kang
    Wang, Xueding
    Cao, Qian
    Qian, Jiaming
    Wu, Kaichun
    Zhu, Xia
    Yang, Hong
    Liang, Jie
    Lin, Lang
    Huang, Zicheng
    Zhang, Yu
    Huang, Yibiao
    Sun, Yinghao
    Xue, Xianmin
    Huang, Min
    Hu, Pinjin
    Lan, Ping
    Gao, Xiang
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (09) : 1592 - 1599
  • [30] Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease
    Dong, Xian-Wen
    Zheng, Qing
    Zhu, Ming-Ming
    Tong, Jing-Lu
    Ran, Zhi-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (25) : 3187 - 3195
12345